# Heparin Sodium

NDC: 63323-519
Generic name: Heparin Sodium
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20200724

FDA application: ANDA212441

## Active ingredients

- HEPARIN SODIUM: 200 [USP'U]/100mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-519"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-519
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=25b0ba06-3274-4a3f-8c39-42d13764ecdf